Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

This study has been completed.
National Cancer Institute (NCI)
Cancer and Leukemia Group B
Information provided by (Responsible Party):
Southwest Oncology Group Identifier:
First received: November 1, 1999
Last updated: October 30, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)